Posts

A ‘sense of urgency’ swirls in the UK pharma regulatory...

The UK government adopted a series of updates to pharmaceutical laws, governing ...

F. Hoffmann-La Roche in cybersecurity: theme innovation...

How many patents did F. Hoffmann-La Roche submit related to cybersecurity last q...

Cara Therapeutics cuts 50% of staff and drops kidney di...

The company ceased activity for its CKD program to sharpen its clinical focus in...

Newly launched Calluna raises $81m to advance monoclona...

Calluna has four monoclonal antibody candidates in the pipeline under developmen...

Investigators fault Lilly plant for manufacturing issues

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Gilead’s Trodelvy fails in lung cancer and raise...

Gilead said Trodelvy, its medicine that combines an antibody with chemotherapy, ...

Opinion: STAT+: Some countries are moving to digital pr...

Some countries are moving to digital prescription drug information for patients....

Opinion: The FDA and FTC need to crack down on TikTok a...

The FDA and FTC need to crack down on influencers advertising prescription drugs.

STAT+: A Harvard course seeks to put food on the table ...

As movements promoting food as medicine gain traction, many medical students wan...

STAT+: In ‘march-in’ rights, some see a tool to lower d...

Some say "march-in" rights can help lower costs for pricey medicines, yet the id...

Why many more people are lining up for a flu shot than ...

Americans who regularly get a flu shot are just the type of people you’d expect ...

STAT+: Physician buy-in will make or break VC firm Gene...

Doctors and other clinicians have their own way of doing things. Will a VC firm ...

STAT+: FDA sets aggressive deadline for inspection over...

The FDA has a huge job ahead of overhauling the way it handles inspections of re...

Rollout of a new malaria vaccine kicks off in Africa

Starting Monday, a new, highly effective malaria vaccine will be rolled out for ...

STAT+: Feds bar Theranos founder Elizabeth Holmes from ...

Theranos founder and ex-CEO Elizabeth Holmes is banned from federal health progr...

Dana-Farber expands studies to be retracted to 6, plus ...

A blogger who questioned 57 papers by Dana-Farber researchers gets quick results...